These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15533236)

  • 1. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.
    McKenna KE
    Photodermatol Photoimmunol Photomed; 2004 Dec; 20(6):289-96. PubMed ID: 15533236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
    Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
    Gasparro FP; Liao B; Foley PJ; Wang XM; McNiff JM
    Environ Mol Mutagen; 1998; 31(2):105-12. PubMed ID: 9544188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired dermal melanocytosis induced by psoralen plus ultraviolet A therapy.
    Nagase K; Hirashima N; Koba S; Inoue T; Misago N; Narisawa Y
    Acta Derm Venereol; 2012 Nov; 92(6):691-2. PubMed ID: 22294134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for skin cancer in organ transplant recipients in Denmark].
    Horn J; Lock-Andersen J; Rasmussen K; Jemec GB
    Ugeskr Laeger; 2005 Jun; 167(25-31):2762-5. PubMed ID: 16014261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis.
    Amber KT; Korta DZ; de Feraudy S; Grando SA
    Clin Exp Dermatol; 2017 Oct; 42(7):833-835. PubMed ID: 28597976
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
    Randle HW
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides with depigmentation secondary to treatment.
    Firoz B; Kovich OI; Latkowski JA
    Dermatol Online J; 2007 Jan; 13(1):18. PubMed ID: 17511951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
    Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E
    Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and transplantation of murine skin cancers induced by methoxsalen plus ultraviolet (320-400 nm) radiation.
    Kripke ML; Morison WL; Parrish JA
    J Natl Cancer Inst; 1982 Apr; 68(4):685-90. PubMed ID: 7040768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.
    Otley CC; Berg D; Ulrich C; Stasko T; Murphy GM; Salasche SJ; Christenson LJ; Sengelmann R; Loss GE; Garces J;
    Br J Dermatol; 2006 Mar; 154(3):395-400. PubMed ID: 16445766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients.
    Smith KJ; Hamza S; Skelton H
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):634-41. PubMed ID: 15061848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinogenic risks of phototherapy and photochemotherapy].
    Roelandts R
    Hautarzt; 1987 Jul; 38(7):388-94. PubMed ID: 3308774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous complications after organ transplantation].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.